DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Metropolis Healthcare Limited — Updates

NSE 1 hr ago·5 Oct 2026, 12:43 pm

Metropolis Healthcare

Metropolis Healthcare has announced a business update for the second quarter of fiscal year 2027. The company has submitted this information to the stock exchanges, providing stakeholders with a progress report on its current operations.

This disclosure is significant for investors as it offers a timely look into the company's performance during the quarter. While specific financial figures are not yet detailed, such updates are crucial for tracking the operational health of a healthcare service provider amidst a competitive market.

Investors should await the detailed quarterly results to assess the company's growth trajectory. Monitoring the management's commentary on market conditions and operational efficiency will be key for understanding the stock's future direction.